Authors
Loading...
Novel macrocyclic peptide speirobactin selectively kills Mycobacterium tuberculosis, suggesting DNA gyrase as the primary target.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: